Podcast

Robert S. Laitman, MD, on Unpacking Schizophrenia: Why a Global Health Approach Is Key

12/19/2018

In part 3 of his podcast series with Consultant360, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA explains the importance of treating his patients’ physical and societal health in addition to their psychiatric health.

Robert S. Laitman, MD, is an internal medicine physician at Bronx Westchester Medical Group in New York. He is on the Board of Directors for the Schizophrenia and Related Disorders Alliance of America, and is also a board member of the National Alliance of Mental Illness - New York. Over the last 10 years, he has developed a practice taking care of people with psychotic disorders after his son, Daniel, received a diagnosis of schizophrenia in 2006.

Dr Laitman and his wife, Dr Ann Mandel Laitman, founded the charity, Team Daniel: Running for Recovery from Mental Illness. Dr Laitman, his family, and his colleague also authored the book, "Clozapine: Meaningful Recovery from Schizophrenia.”

Published in partnership with  SARDAA

References:

1. National health and nutrition examination survey. National Center for Health Statistics. Centers for Disease Control and Prevention. Page last updated October 30, 2018. https://www.cdc.gov/nchs/nhanes/index.htm. Accessed on December 19, 2018.

2. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507-2520. https://doi.org/10.1016/S0140-6736(16)30272-0.

Related Content

Cardiovascular Diseases
Cardiovascular Diseases
Paul Mather, MD, on Chronic Congestive Heart Failure
08/20/2018
In part 3 of this 4-part series, Dr Paul Mather from the Perelman School of Medicine talks about the incidence and prevalence of chronic congestive HF, etiologies for HF, treatment of chronic systolic HF,...
08/20/2018
NAFLD
NAFLD
Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD
07/15/2020
He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
07/15/2020
asthma
asthma
IL-6 as a Biomarker for Asthma Exacerbations
04/15/2022
In this podcast, Michael Peters, MD, talks about his team's cross-sectional analysis on the use of blood eosinophils and IL-6 as predictive biomarkers of the exacerbation-prone asthma phenotype over 3...
04/15/2022
Pulmonology
Pulmonology
John Mastronarde, MD, on Treating COPD in Primary Care
12/20/2017
Dr John Mastronarde, from the Oregon Clinic, explains how COPD is classified, the GOLD guidelines, and treating patients with COPD.
12/20/2017
Cardiovascular Diseases
Cardiovascular Diseases
Treatment of Dyslipidemia
07/11/2022
Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
07/11/2022